Public trial registry of the CCC-Munich

Trial CA209-577

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CA209-577
World
Full title
:

Ende der Rekrutierung! A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer Z.:335

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Esophageal cancer
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2016-09-16
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet - Therapieart: adjuvant

Participants
Function Prename Surname Organization
World Responsible contact Sylvie Lorenzen 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier